期刊
PRIMARY CARE DIABETES
卷 14, 期 5, 页码 558-563出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.pcd.2020.06.010
关键词
SARS-CoV-2; COVID-19; Diabetes mellitus
资金
- MSD
- AstraZeneca
- Sanofi
- Novo Nordisk
- Eli Lilly
- Boehringer-Ingelheim
- Novartis
- Pfizer
- GSK
- Trigocare
- Libytec
- Valeant
- Servier
- ELPEN
- Lilly
- Bayer
- Amgen
COVID-19 and diabetes are currently two global pandemics. Epidemiological studies indicate that diabetes is the second most common comorbidity in COVID-19. This review aims to summarize currently available data about prevalence, possible pathophysiological mechanisms and management of patients with diabetes and COVID-19. (C) 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
